Showing results (191-200 of 227) with videos related to
Sort By:
Pageof 23
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 20, 2022
Nonsense codons suppression. An acute toxicity study of three optimized TRIDs in murine model, safety and tolerability evaluationFederica Corrao, Maria Grazia Zizzo, Marco Tutone, et al.Neurosurgical Review|October 29, 2024
The role of surgery in recurrent local cerebral metastases: a multi-institutional retrospective analysisStefano Telera, Luigino Tosatto, Roberto Colasanti, et al.Journal of Translational Medicine|March 24, 2023
The Glioma-IRE project - Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approachVeronica Villani, Beatrice Casini, Antonio Tanzilli, et al.Biomedicines|April 23, 2022
Novel Translational Read-through-Inducing Drugs as a Therapeutic Option for Shwachman-Diamond SyndromeValentino Bezzerri, Laura Lentini, Martina Api, et al.Frontiers in Oncology|January 1, 2024
Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated <i>MGMT</i> gene promoter: RACTAC, a phase II multicenter trialAndrea Pace, Giuseppe Lombardi, Veronica Villani, et al.European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trialMichele Reni, Warren Mason, Francesco Zaja, et al.Journal of the Peripheral Nervous System : JPNS|September 18, 2007
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity ScaleGuido Cavaletti, Barbara Frigeni, Francesca Lanzani, et al.Journal of Experimental & Clinical Cancer Research : CR|January 20, 2011
Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating centerAlessandra Fabi, Alessandra Felici, Giulio Metro, et al.Neuro-Oncology Practice|October 1, 2021
Identification of characteristics that determine behavioral and personality changes in adult glioma patientsHanneke Zwinkels, Linda Dirven, Helen J Bulbeck, et al.Neuro-Oncology|October 15, 2021
IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroupsRoberta Rudà, Francesco Bruno, Tamara Ius, et al.Pageof 23